bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.10.15.759370

Circular DNA interacts with Cathelicidin LL37 to efficiently activate plasmacytoid dendritic cells

Su, L.·Ejikemeuwa, A.·He, J.·Li, G.·Yuan, W.·Lu, W.·Wang, Y.·Zhang, Y.
View original source ↗Export metadata ↓

Abstract

Circulating cell-free DNA in inflamed tissues contains different forms of DNA, including extrachromosomal circular DNA (eccDNA). The role of DNA topology in innate immune sensing remains poorly understood. Here we show that circular DNA is a potent ligand for human plasmacytoid dendritic cells (pDCs) and that the cathelicidin host defense peptide LL37 selectively enhances circular DNA-induced activation. Across eccDNA, minicircle and synthetic circular DNA species, LL37 strikingly amplified type I interferon (IFN-I) and pro-inflammatory cytokine production, whereas linearized counterparts of identical sequence remained inactive. LL37-circular DNA complexes signaled through endosomal TLR9, as activation was abrogated by chloroquine and by the TLR9 antagonist IRS869. Mechanistically, LL37 promoted preferential retention of circular DNA in EEA1-positive early endosomes, and surface plasmon resonance revealed enhanced TLR9 binding to circular versus linear DNA, without differential LL37 binding. DNA topology rather than sequence, therefore, determines the immunostimulatory potential of cell-free DNA in pDCs. These findings define a mechanism by which LL37 and circular DNA jointly drive TLR9-dependent IFN-I responses, with implications for autoimmunity, cancer and nucleic acid therapeutics.

Explore related subjects

immunologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Su, L., Ejikemeuwa, A., He, J., Li, G., Yuan, W., Lu, W., Wang, Y., Zhang, Y.. 2026-10-21. Circular DNA interacts with Cathelicidin LL37 to efficiently activate plasmacytoid dendritic cells. https://doi.org/10.64898/2026.10.15.759370

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Distinct profiles and antibody production by splenic and lymph node antibody-secreting cells in Trypanosoma cruzi infection

Evidence from bone marrow and intestinal lamina propria studies indicates that antibody-secreting cell (ASC) characteristics are shaped by the local microenvironment; yet whether secondary lymphoid organs harbor distinct ASC populations during infection remains unclear. Here, we investigated plasmablasts (PB) from the spleen and inguinal lymph nodes (LN) in acute Trypanosoma cruzi infection. Although PB from both tissues expressed canonical ASC markers, they displayed distinct transcriptional, phenotypic, and functional profiles. Splenic PB upregulated genes and proteins associated with inflammation, immunomodulation, and B-cell interactions. Activated and naive B cells also exhibited tissue-specific transcriptional programs, suggesting that local cues influence B-cell differentiation. Consistent with these differences, spleens from infected mice contained more T follicular helper cells, whereas LN were enriched in regulatory T cells. High-dimensional flow cytometry identified multiple PB subsets differentially represented between tissues. Functionally, splenic PB secreted higher levels of IgM, IgA, and IgG, including both parasite-specific and autoreactive antibodies. In contrast, LN PB preferentially produced IgG against peptide 72 of the shed acute-phase antigen (SAPA), despite lower overall T. cruzi-specific antibody production. These findings demonstrate that secondary lymphoid organs harbor distinct PB populations adapted to their local microenvironments during acute infection

immunology↗
bioRxiv2026

Intrinsic immune receptor triggering mechanism informs rational chimeric receptor design

The T cell receptor (TCR) couple antigen recognition to T-cell activation and immune homeostasis. As an eight-subunit assembly, TCR activation operates as a highly coordinated, multi-subunit signaling event. However, which subunit serves as the primary trigger upon ligand engagement still remains unresolved. we identify CD3{varepsilon} as a triggering subunit whose intracellular domain (ICD) is released from the plasma membrane during TCR activation. Elevated membrane tension facilitates this transition from a membrane-proximal to a membrane-distal conformation. The released ICD forms condensates through phase separation with free or co-receptor-associated Lck. These condensates recruit additional CD3{varepsilon} ICDs from neighboring TCRs, triggering resting receptors and promoting further recruitment of TCRs and Lck to amplify proximal signaling. The CD3{varepsilon} ICD alone support robust T cell activation independently of its own ITAM. We observe a similar triggering mechanism in several activating receptors in T and nature killer (NK) cell. These findings support a unifying model in which designated subunits initiate multi-subunit immune receptor activation through phase separation with key kinases. Guided by this model, we engineered triggering molecules (TRIG) that lack canonical intracellular signaling modules. These TRIG molecules recruit endogenous immune receptors in a ligand-dependent manner and efficiently activate both T cells and NK cells. This mechanism provides a basis for designing chimeric receptors that activate immune cells through endogenous receptor signaling.

immunology↗
bioRxiv2026

Neutralizing vaccination against viral interleukin-6 from a primate rhadinovirus

Herpesviruses are ancient viruses that devote a significant fraction of their protein-coding potential to interference with host immunity. Diverse herpesviruses encode proteins with similarity to host MHC molecules, interferon regulatory factors, complement regulators, G-protein coupled receptors, chemokines, and cytokines. Certain gammaherpesviruses, including Kaposi sarcoma-associated herpesvirus (KSHV) and rhesus rhadinovirus (RRV), encode viral cytokines similar to host IL-6, called viral IL-6 (vIL-6). The potential of vIL-6 to act as a protective vaccine antigen against these rhadinoviruses remains under-explored. We isolated a new RRV strain, which encodes virion surface proteins similar to those of previous isolates and a vIL-6 that is nearly identical. We found that, although unmodified vIL-6 is a poor immunogen eliciting low neutralizing titers, vIL-6-Fc fusion protein elicits high-titer responses after either one or two doses. We detected no adverse effects related to cytokine activity, nor interference with concomitantly administered vaccine against the RRV glycoprotein B. Our results demonstrate an approach for eliciting neutralizing antibodies against a highly conserved viral protein that contributes to rhadinovirus persistence and oncogenesis.

immunology↗